{"id":574218,"date":"2026-02-24T08:50:26","date_gmt":"2026-02-24T08:50:26","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/?p=574218"},"modified":"2026-06-30T08:24:54","modified_gmt":"2026-06-30T08:24:54","slug":"navigating-fda-complete-response-letters-clarivate","status":"publish","type":"post","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/blog\/navigating-fda-complete-response-letters-clarivate\/","title":{"rendered":"Complete Response Letter\u3092\u8aad\u307f\u89e3\u304f\uff1aClarivate\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u304c\u652f\u63f4\u3059\u308b\u627f\u8a8d\u53d6\u5f97\u3078\u306e\u9053\u7b4b"},"content":{"rendered":"<p>\u533b\u85ac\u54c1\u306e\u5e02\u5834\u6295\u5165\u307e\u3067\u306e\u9053\u306e\u308a\u304c\u4e88\u671f\u305b\u306c\u898f\u5236\u4e0a\u306e\u63aa\u7f6e\u306b\u3088\u3063\u3066\u8907\u96d1\u5316\u3057\u305f\u3068\u304d\u3001\u88fd\u85ac\u4f01\u696d\u306f\u91cd\u5927\u306a\u5206\u5c90\u70b9\u306b\u7acb\u305f\u3055\u308c\u307e\u3059\u3002\u52b9\u679c\u7684\u304b\u3064\u8fc5\u901f\u306b\u5bfe\u5fdc\u3059\u308b\u304b\u3001\u3042\u308b\u3044\u306f\u958b\u767a\u30bf\u30a4\u30e0\u30e9\u30a4\u30f3\u3068\u7af6\u4e89\u512a\u4f4d\u306e\u53cc\u65b9\u3092\u5931\u3046\u304b\u3001\u3068\u3044\u3046\u5c40\u9762\u3067\u3059\u3002 <a href=\"https:\/\/clarivate.com\/ja\/drugs-to-watch\/\"> Clarivate\u306e\u300cDrugs to Watch 2026\u300d\u30ec\u30dd\u30fc\u30c8<\/a>\u3067\u53d6\u308a\u4e0a\u3052\u305f\u6cbb\u7642\u85ac\u306e\u3046\u3061\u3001Sanofi\u306etolebrutinib\u3068Corcept Therapeutics\u306erelacorilant\u306e2\u5264\u306f\u30012025\u5e74\u672b\u306b\u307e\u3055\u306b\u3053\u306e\u3088\u3046\u306a\u5f8c\u9000\u306b\u76f4\u9762\u3057\u307e\u3057\u305f\u3002FDA\u306f2025\u5e7412\u670823\u65e5\u306b\u3001\u975e\u518d\u767a\u6027\u4e8c\u6b21\u9032\u884c\u578b\u591a\u767a\u6027\u786c\u5316\u75c7\uff08nrSP-MS\uff09\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306e<a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2025\/2025-12-24-06-00-00-3210238\" target=\"_blank\" rel=\"noopener\">relacorilant<\/a>\u202f\u306b\u5bfe\u3057\u3066\u3001\u307e\u305f2025\u5e7412\u670830\u65e5\u306b\u3001\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306e<a href=\"https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2025\/2025-12-24-06-00-00-3210238\" target=\"_blank\" rel=\"noopener\">relacorilant<\/a>\u306b\u5bfe\u3057\u3066\u3001Complete Response Letter\uff08CRL\uff09\u3092\u9001\u4ed8\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u3053\u308c\u3089\u306e\u5224\u65ad\u306f\u591a\u304f\u306e\u95a2\u4fc2\u8005\u306b\u3068\u3063\u3066\u610f\u5916\u306a\u3082\u306e\u3067\u3057\u305f\u3002tolebrutinib\u306f\u512a\u5148\u5be9\u67fb\u304a\u3088\u3073\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u30bb\u30e9\u30d4\u30fc\u6307\u5b9a\u306e\u4e21\u65b9\u3092\u53d7\u3051\u3066\u304a\u308a\u3001\u4e00\u65b9\u3067relacorilant\u306e\u4e3b\u8981\u8a66\u9a13\u3067\u3042\u308bGRACE\u8a66\u9a13\u306f\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3092\u9054\u6210\u3057\u3001\u3055\u3089\u306bGRADIENT\u8a66\u9a13\u306e\u78ba\u8a8d\u7684\u30c7\u30fc\u30bf\u306b\u3088\u308b\u88cf\u4ed8\u3051\u3082\u3042\u308a\u307e\u3057\u305f\u3002<\/p>\n<h3><strong>Complete Response Letter\uff08CRL\uff09\u3068\u306f\u4f55\u304b\uff1f <\/strong><\/h3>\n<p>CRL\u306f\u3001FDA\u306e\u300capprovable letter\u300d\u304a\u3088\u3073\u300cnot approvable letter\u300d\u306b\u4ee3\u308f\u308b\u3082\u306e\u3068\u3057\u30662008\u5e74\u306b\u5c0e\u5165\u3055\u308c\u3001\u7533\u8acb\u5185\u5bb9\u306e\u307e\u307e\u3067\u306f\u627f\u8a8d\u3067\u304d\u306a\u3044\u3053\u3068\u3092\u4e2d\u7acb\u7684\u306b\u4f1d\u3048\u308b\u4ed5\u7d44\u307f\u3068\u3057\u3066\u8a2d\u8a08\u3055\u308c\u307e\u3057\u305f\u3002\u3082\u3063\u3068\u3082\u3001\u516c\u5f0f\u306b\u306f\u4e2d\u7acb\u3067\u3042\u3063\u3066\u3082\u3001CRL\u306b\u306f\u5927\u304d\u306a\u610f\u5473\u304c\u3042\u308a\u307e\u3059\u3002FDA\u304c\u8a8d\u8b58\u3057\u305f\u5177\u4f53\u7684\u306a\u4e0d\u5099\u3092\u8a73\u8ff0\u3057\u3001\u901a\u5e38\u306f\u305d\u308c\u3089\u306b\u5bfe\u5fdc\u3059\u308b\u305f\u3081\u306e\u624b\u9806\u3092\u63d0\u793a\u3059\u308b\u304b\u3089\u3067\u3059\u3002\u4e00\u822c\u7684\u306a\u7406\u7531\u3068\u3057\u3066\u306f\u3001\u8ffd\u52a0\u30c7\u30fc\u30bf\u3092\u8981\u3059\u308b\u5b89\u5168\u6027\u307e\u305f\u306f\u6709\u52b9\u6027\u4e0a\u306e\u61f8\u5ff5\u3001\u88fd\u9020\u307e\u305f\u306f\u54c1\u8cea\u7ba1\u7406\u4e0a\u306e\u4e0d\u5099\u3001\u4e0d\u5341\u5206\u306a\u30ea\u30b9\u30af\u7ba1\u7406\u8a08\u753b\u3001\u306a\u3089\u3073\u306b\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u8a55\u4fa1\u306b\u5fc5\u8981\u306a\u6839\u62e0\u306e\u4e0d\u8db3\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n<p><strong>CRL\u306f\u5f8c\u9000\u3067\u306f\u3042\u308b\u304c\u3001\u975e\u627f\u8a8d\u3067\u306f\u306a\u3044<\/strong><\/p>\n<p>CRL\u306f\u78ba\u304b\u306b\u5f8c\u9000\u3067\u306f\u3042\u308a\u307e\u3059\u304c\u3001\u975e\u627f\u8a8d\u3092\u610f\u5473\u3059\u308b\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u304a\u3088\u305d41%\u306e\u7533\u8acb\u304cCRL\u3092\u53d7\u3051\u53d6\u308a\u3001\u305d\u306e\u3046\u3061\u534a\u6570\u8d85\u306f\u6700\u7d42\u7684\u306b\u627f\u8a8d\u306b\u81f3\u308a\u307e\u3059\u3002\u3053\u3046\u3057\u305f\u5224\u65ad\u306e\u80cc\u666f\u306b\u4f55\u304c\u3042\u3063\u305f\u306e\u304b\u3001\u305d\u3057\u3066\u6b21\u306b\u4f55\u304c\u8d77\u3053\u308b\u306e\u304b\u3092\u7406\u89e3\u3059\u308b\u3053\u3068\u306f\u3001\u898f\u5236\u5f53\u5c40\u306e\u671f\u5f85\u306b\u5bfe\u5fdc\u3057\u3088\u3046\u3068\u3059\u308b\u958b\u767a\u4f01\u696d\u306b\u3068\u3063\u3066\u91cd\u8981\u306a\u793a\u5506\u3092\u4e0e\u3048\u307e\u3059\u3002<\/p>\n<p>Sanofi\u304a\u3088\u3073Corcept Therapeutics\u306b\u3068\u3063\u3066\u3001\u4eca\u5f8c\u306e\u9053\u7b4b\u306b\u306f\u9ad8\u5ea6\u306a\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3001\u5148\u4f8b\u5206\u6790\u3001\u305d\u3057\u3066\u6226\u7565\u7684\u306a\u30a8\u30d3\u30c7\u30f3\u30b9\u5275\u51fa\u304c\u6c42\u3081\u3089\u308c\u307e\u3059\u3002Clarivate\u306e\u7d71\u5408\u578bAI\u5bfe\u5fdc\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u898f\u5236\u5f53\u5c40\u306e\u610f\u601d\u6c7a\u5b9a\u652f\u63f4\u3001\u518d\u7533\u8acb\u6226\u7565\u306e\u5f37\u5316\u3001\u305d\u3057\u3066\u6cbb\u7642\u85ac\u3092\u60a3\u8005\u3078\u5c4a\u3051\u308b\u524d\u9032\u3092\u5f8c\u62bc\u3057\u3059\u308b\u3088\u3046\u8a2d\u8a08\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>\u898f\u5236\u4e0a\u306e\u8ab2\u984c\u304c\u7570\u306a\u308c\u3070\u3001\u5fc5\u8981\u306a\u6226\u7565\u3082\u7570\u306a\u308b<\/strong><\/h3>\n<p>\u500b\u5225\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u691c\u8a0e\u3059\u308b\u524d\u306b\u91cd\u8981\u306a\u306e\u306f\u3001Sanofi\u3068Corcept\u304c\u76f4\u9762\u3057\u3066\u3044\u308bCRL\u4e0a\u306e\u8ab2\u984c\u304c\u672c\u8cea\u7684\u306b\u7570\u306a\u308a\u3001\u305d\u308c\u305e\u308c\u306b\u5408\u308f\u305b\u305f\u5bfe\u5fdc\u304c\u5fc5\u8981\u3060\u3068\u8a8d\u8b58\u3059\u308b\u3053\u3068\u3067\u3059\u3002<\/p>\n<p>Sanofi\u306etolebrutinib\u304c\u76f4\u9762\u3057\u3066\u3044\u308b\u306e\u306f\u3001\u5b89\u5168\u6027\u306b\u7126\u70b9\u3092\u5f53\u3066\u305fCRL\u3067\u3042\u308a\u3001FDA\u306f\u91cd\u7be4\u306a\u85ac\u5264\u6027\u809d\u969c\u5bb3\uff08DILI\uff09\u306e\u30ea\u30b9\u30af\u3092\u300c\u91cd\u5927\u304b\u3064\u7570\u4f8b\u306b\u9ad8\u3044\u300d\u3068\u4f4d\u7f6e\u4ed8\u3051\u307e\u3057\u305f\u3002FDA\u306f\u3055\u3089\u306b\u3001\u300c\u5229\u76ca\u304c\u660e\u78ba\u306b\u793a\u3055\u308c\u3001\u304b\u3064\u305d\u306e\u5229\u76ca\u304c\u91cd\u7be4\u306aDILI\u306e\u91cd\u5927\u306a\u30ea\u30b9\u30af\u3092\u4e0a\u56de\u308b\u3068\u671f\u5f85\u3067\u304d\u308b\u60a3\u8005\u96c6\u56e3\u3092\u7279\u5b9a\u3067\u304d\u306a\u304b\u3063\u305f\u300d\u3068\u7d50\u8ad6\u3065\u3051\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306fSanofi\u306b\u5bfe\u3057\u3001\u30ea\u30b9\u30af\u6700\u5c0f\u5316\u6226\u7565\u306e\u5f37\u5316\u3001\u3088\u308a\u4f4e\u30ea\u30b9\u30af\u306a\u60a3\u8005\u30b5\u30d6\u30b0\u30eb\u30fc\u30d7\u306e\u7279\u5b9a\u3001\u3042\u308b\u3044\u306f\u8ffd\u52a0\u306e\u5b89\u5168\u6027\u30a8\u30d3\u30c7\u30f3\u30b9\u306e\u5275\u51fa\u3092\u6c42\u3081\u308b\u3082\u306e\u3067\u3059\u3002<\/p>\n<p>\u4e00\u65b9\u3001Corcept\u306erelacorilant\u304c\u53d7\u3051\u53d6\u3063\u305f\u306e\u306f\u3001\u30a8\u30d3\u30c7\u30f3\u30b9\u306e\u5341\u5206\u6027\u306b\u95a2\u3059\u308bCRL\u3067\u3057\u305f\u3002FDA\u306fGRACE\u8a66\u9a13\u304c\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3092\u9054\u6210\u3057\u305f\u3053\u3068\u306f\u8a8d\u3081\u3064\u3064\u3082\u3001\u300cCorcept\u304c\u6709\u52b9\u6027\u306b\u95a2\u3059\u308b\u8ffd\u52a0\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u63d0\u793a\u3057\u306a\u3044\u9650\u308a\u3001relacorilant\u306b\u3064\u3044\u3066\u826f\u597d\u306a\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u8a55\u4fa1\u306b\u306f\u5230\u9054\u3067\u304d\u306a\u3044\u300d\u3068\u8ff0\u3079\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u3001\u7570\u8cea\u6027\u306e\u9ad8\u3044\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u60a3\u8005\u96c6\u56e3\u5168\u4f53\u306b\u304a\u3044\u3066\u3001\u81e8\u5e8a\u7684\u610f\u7fa9\u3068\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u3092\u3088\u308a\u5305\u62ec\u7684\u306b\u793a\u3059\u5fc5\u8981\u304c\u3042\u308b\u3053\u3068\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>Clarivate\u306e\u7d71\u5408\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u57fa\u76e4\u306f\u3044\u304b\u306bCRL\u5bfe\u5fdc\u3092\u652f\u63f4\u3059\u308b\u304b<\/strong><\/h3>\n<p>Clarivate\u306e\u7d71\u5408\u30c7\u30fc\u30bf\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068AI\u642d\u8f09\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306b\u5bfe\u3057\u3066\u3001\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3001\u5206\u6790\u529b\u3001\u305d\u3057\u3066\u6226\u7565\u7684\u6d1e\u5bdf\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002AI\u3092\u6d3b\u7528\u3057\u305f\u5f53\u793e\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\u306f\u3001\u533b\u85ac\u54c1\u958b\u767a\u304a\u3088\u3073\u5546\u696d\u5316\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u306b\u308f\u305f\u308a\u3001\u300c\u554f\u3044\u300d\u304b\u3089\u300c\u6d1e\u5bdf\u300d\u307e\u3067\u306e\u6642\u9593\u3092\u5287\u7684\u306b\u77ed\u7e2e\u3067\u304d\u307e\u3059\u3002\u5f93\u6765\u306f\u6570\u9031\u9593\u306e\u624b\u4f5c\u696d\u5206\u6790\u3092\u8981\u3057\u305f\u30d7\u30ed\u30bb\u30b9\u3092\u3001\u6570\u6642\u9593\u3067\u5f97\u3089\u308c\u308b\u6d1e\u5bdf\u3078\u3068\u5909\u3048\u308b\u3053\u3068\u304c\u53ef\u80fd\u3067\u3059\u3002<\/p>\n<p>\u3053\u306e\u7d71\u5408\u30a2\u30d7\u30ed\u30fc\u30c1\u306f\u3001Drugs to Watch\u306e\u9078\u5b9a\u306b\u304a\u3044\u3066\u7279\u306b\u6709\u7528\u3067\u3042\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u307e\u3057\u305f\u3002\u305d\u3057\u3066\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306b\u3068\u3063\u3066\u3001\u305d\u306e\u4fa1\u5024\u306fCRL\u3078\u306e\u5bfe\u5fdc\u306b\u3082\u305d\u306e\u307e\u307e\u5f53\u3066\u306f\u307e\u308a\u307e\u3059\u3002\u306a\u305c\u306a\u3089\u3001\u305d\u3053\u3067\u306f\u8907\u6570\u306e\u30c7\u30fc\u30bf\u30bd\u30fc\u30b9\u3068\u5206\u6790\u8996\u70b9\u3092\u8fc5\u901f\u306b\u7d71\u5408\u3059\u308b\u5fc5\u8981\u304c\u3042\u308b\u304b\u3089\u3067\u3059\u3002\u4fe1\u983c\u3067\u304d\u308b\u30bd\u30fc\u30b9\u304b\u3089\u306e\u91cd\u8981\u60c5\u5831\u3092\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u3067\u66f4\u65b0\u3059\u308b\u3053\u3068\u3067\u3001\u898f\u5236\u5224\u65ad\u304c\u6f5c\u5728\u5e02\u5834\u3078\u53ca\u307c\u3059\u5f71\u97ff\u306e\u518d\u8a55\u4fa1\u3001\u60a3\u8005\u3078\u306e\u5f71\u97ff\u306e\u7406\u89e3\u3001\u3042\u308b\u3044\u306fCRL\u5f8c\u306e\u9032\u8def\u5224\u65ad\u306a\u3069\u306b\u304a\u3044\u3066\u3001\u4fca\u654f\u306a\u5bfe\u5fdc\u3092\u652f\u3048\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>\u3088\u308a\u5f37\u56fa\u306a\u518d\u7533\u8acb\u3092\u53ef\u80fd\u306b\u3059\u308bClarivate\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3 <\/strong><\/h3>\n<p>Clarivate\u306f\u3001\u7814\u7a76\u958b\u767a\u304b\u3089\u5546\u696d\u5316\u307e\u3067\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u3092\u30ab\u30d0\u30fc\u3059\u308b\u3001AI\u3067\u5f37\u5316\u3055\u308c\u305f10\u7a2e\u306e\u7d71\u5408\u30c7\u30fc\u30bf\u30bb\u30c3\u30c8\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u4e2d\u3067\u3082\u3001CRL\u5bfe\u5fdc\u306b\u304a\u3044\u3066\u7279\u306b\u91cd\u8981\u3068\u306a\u308b\u3082\u306e\u306f\u6b21\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<ol>\n<li><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/research-development\/regulatory-compliance-intelligence\/regulatory-intelligence-solutions\/\">Cortellis Regulatory Intelligence\uff08AI\u642d\u8f09Regulatory Assistant\u3092\u542b\u3080\uff09\uff1a\u4f8b\uff09\u5148\u4f8b\u5206\u6790\u3001\u898f\u5236\u6226\u7565\u306e\u7b56\u5b9a\u3001FDA\u304c\u6c42\u3081\u308b\u30a8\u30d3\u30c7\u30f3\u30b9\u6c34\u6e96\u306e\u7406\u89e3 <\/a><\/li>\n<li><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/research-development\/discovery-development\/cortellis-clinical-trials-intelligence\/\">Cortellis Clinical Trials Intelligence\uff1a\u4f8b\uff09\u5b89\u5168\u6027\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u5f37\u5316\u30d7\u30ed\u30c8\u30b3\u30eb\u3084\u3001\u6210\u529f\u78ba\u7387\u306e\u9ad8\u3044\u60a3\u8005\u30b5\u30d6\u30b0\u30eb\u30fc\u30d7\u8a66\u9a13\u306e\u8a2d\u8a08<\/a><\/li>\n<li><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/real-world-data\/drg-fusion\/?utm_content=dtw-blog-series&amp;utm_term=blog-1&amp;campaignname=Drugs_to_Watch_Annual_Report_LeadGen_LS_Global_2026&amp;campaignid=701VO00000nqEKYYA2\">DRG Fusion<\/a> DRG Fusion\uff08\u30ea\u30a2\u30eb\u30ef\u30fc\u30eb\u30c9\u30c7\u30fc\u30bf\u89e3\u6790\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\uff09\uff1a\u4f8b\uff09\u30ea\u30a2\u30eb\u30ef\u30fc\u30eb\u30c9\u30bd\u30fc\u30b9\u304b\u3089\u8ffd\u52a0\u306e\u6709\u52b9\u6027\u30fb\u5b89\u5168\u6027\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u5275\u51fa\u3057\u3001\u3088\u308a\u4f4e\u30ea\u30b9\u30af\u306a\u30b5\u30d6\u30b0\u30eb\u30fc\u30d7\u3092\u7279\u5b9a<\/li>\n<li><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/portfolio-strategy\/market-assessment\/epidemiology-intelligence\/?utm_content=dtw-blog-series&amp;utm_term=blog-1&amp;campaignname=Drugs_to_Watch_Annual_Report_LeadGen_LS_Global_2026&amp;campaignid=701VO00000nqEKYYA2\">Epidemiology Intelligence<\/a>Epidemiology Intelligence\uff1a\u4f8b\uff09\u3088\u308a\u4f4e\u30ea\u30b9\u30af\u306a\u30b5\u30d6\u30b0\u30eb\u30fc\u30d7\u306b\u304a\u3051\u308b\u5bfe\u8c61\u60a3\u8005\u96c6\u56e3\u3092\u5b9a\u91cf\u5316\u3057\u3001\u6700\u3082\u660e\u78ba\u306b\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u304c\u793a\u3055\u308c\u308b\u96c6\u56e3\u3092\u5b9a\u7fa9<\/li>\n<li><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/portfolio-strategy\/competitive-intelligence\/cortellis-competitive-intelligence-analytics\/?utm_content=dtw-blog-series&amp;utm_term=blog-1&amp;campaignname=Drugs_to_Watch_Annual_Report_LeadGen_LS_Global_2026&amp;campaignid=701VO00000nqEKYYA2\">Cortellis Competitive Intelligence<\/a>Cortellis Competitive Intelligence\uff1a\u4f8b\uff09\u958b\u767a\u9577\u671f\u5316\u306e\u9593\u3082\u6226\u7565\u7684\u306a\u7af6\u4e89\u74b0\u5883\u628a\u63e1\u3092\u7dad\u6301\u3057\u3001\u88fd\u85ac\u696d\u754c\u5411\u3051\u4e88\u6e2c\u5206\u6790\u3092\u7528\u3044\u3066\u610f\u601d\u6c7a\u5b9a\u304c\u4e0a\u5e02\u6642\u671f\u3084\u58f2\u4e0a\u4e88\u6e2c\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u3092\u7406\u89e3<\/li>\n<li><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/portfolio-strategy\/market-assessment\/disease-landscape-and-forecast\/?utm_content=dtw-blog-series&amp;utm_term=blog-1&amp;campaignname=Drugs_to_Watch_Annual_Report_LeadGen_LS_Global_2026&amp;campaignid=701VO00000nqEKYYA2\">Disease Landscape &amp; Forecast<\/a>: \u4f8b\uff09\u958b\u767a\u9577\u671f\u5316\u306e\u9593\u306b\u304a\u3051\u308b\u7af6\u4e89\u74b0\u5883\u628a\u63e1\u3068\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u6226\u7565\u306e\u7dad\u6301<\/li>\n<li><a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/commercialization\/market-access\/?utm_content=dtw-blog-series&amp;utm_term=blog-1&amp;campaignname=Drugs_to_Watch_Annual_Report_LeadGen_LS_Global_2026&amp;campaignid=701VO00000nqEKYYA2\">Access and reimbursement intelligence<\/a>: \u4f8b\uff09\u958b\u767a\u9577\u671f\u5316\u306e\u9593\u306b\u5e02\u5834\u30a2\u30af\u30bb\u30b9\u6226\u7565\u3092\u69cb\u7bc9\u30fb\u7cbe\u7dfb\u5316\u3057\u3001\u627f\u8a8d\u5f8c\u306e\u8fc5\u901f\u306a\u666e\u53ca\u3092\u52a0\u901f<\/li>\n<\/ol>\n<p>The next post in this series examines \u3053\u306e\u30b7\u30ea\u30fc\u30ba\u306e\u6b21\u56de\u8a18\u4e8b\u3067\u306f\u3001\u3053\u308c\u3089\u306e<a href=\"https:\/\/clarivate.com\/life-sciences-healthcare\/blog\/tolebrutinib-crl-safety-overrides-efficacy\">AI\u642d\u8f09Clarivate\u30c4\u30fc\u30eb\u304c\u3001\u898f\u5236\u7533\u8acb\u306b\u304a\u3051\u308b\u30ea\u30b9\u30af\u30fb\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u8a55\u4fa1\u3078\u306e\u5bfe\u5fdc\u3092\u4f01\u696d\u306b\u3069\u306e\u3088\u3046\u306b\u652f\u63f4\u3067\u304d\u308b\u304b\u3092\u691c\u8a0e\u3057\u307e\u3059\u3002<\/a><\/p>\n<p><em><a href=\"https:\/\/clarivate.com\/drugs-to-watch\/?utm_content=dtw-blog-series\">2026\u5e74\u7248 Drugs to Watch<\/a>\u306e\u8a73\u7d30\u3082\u305c\u3072\u3054\u89a7\u304f\u3060\u3055\u3044\u3002\u307e\u305f\u3001Clarivate\u304cAI\u30c4\u30fc\u30eb\u3092\u3069\u306e\u3088\u3046\u306b\u6d3b\u7528\u3057\u3001\u9867\u5ba2\u304c\u3088\u308a\u826f\u3044\u610f\u601d\u6c7a\u5b9a\u3092\u3088\u308a\u8fc5\u901f\u306b\u884c\u3048\u308b\u3088\u3046\u652f\u63f4\u3057\u3066\u3044\u308b\u304b\u306b\u3064\u3044\u3066\u3082\u3054\u78ba\u8a8d\u3044\u305f\u3060\u3051\u307e\u3059\u3002<br \/>\n<\/em><br \/>\n\u203b\u672c\u8a18\u4e8b\u306fClarivate.com\u306e\u82f1\u8a9e\u539f\u6587\u3092AI\u7ffb\u8a33\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u533b\u85ac\u54c1\u306e\u5e02\u5834\u6295\u5165\u307e\u3067\u306e\u9053\u306e\u308a\u304c\u4e88\u671f\u305b\u306c\u898f\u5236\u4e0a\u306e\u63aa\u7f6e\u306b\u3088\u3063\u3066\u8907\u96d1\u5316\u3057\u305f\u3068\u304d\u3001\u88fd\u85ac\u4f01\u696d\u306f\u91cd\u5927\u306a\u5206\u5c90\u70b9\u306b\u7acb\u305f\u3055\u308c\u307e\u3059\u3002\u52b9\u679c\u7684\u304b\u3064\u8fc5\u901f\u306b\u5bfe\u5fdc\u3059\u308b\u304b\u3001\u3042\u308b\u3044\u306f\u958b\u767a\u30bf\u30a4\u30e0\u30e9\u30a4\u30f3\u3068\u7af6\u4e89\u512a\u4f4d\u306e\u53cc\u65b9\u3092\u5931\u3046\u304b\u3001\u3068\u3044\u3046\u5c40\u9762\u3067\u3059\u3002 Clarivate\u306e\u300cDrugs to Watch 2026\u300d\u30ec\u30dd\u30fc\u30c8\u3067\u53d6\u308a\u4e0a\u3052\u305f\u6cbb\u7642\u85ac\u306e\u3046\u3061\u3001Sanofi\u306etolebrutinib\u3068Corcept Therapeutics\u306erelacorilant\u306e2\u5264\u306f\u30012025\u5e74\u672b\u306b\u307e\u3055\u306b\u3053\u306e\u3088\u3046\u306a\u5f8c\u9000\u306b\u76f4\u9762\u3057\u307e\u3057\u305f\u3002FDA\u306f2025\u5e7412\u670823\u65e5\u306b\u3001\u975e\u518d\u767a\u6027\u4e8c\u6b21\u9032\u884c\u578b\u591a\u767a\u6027\u786c\u5316\u75c7\uff08nrSP-MS\uff09\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306erelacorilant\u202f\u306b\u5bfe\u3057\u3066\u3001\u307e\u305f2025\u5e7412\u670830\u65e5\u306b\u3001\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306erelacorilant\u306b\u5bfe\u3057\u3066\u3001Complete Response Letter\uff08CRL\uff09\u3092\u9001\u4ed8\u3057\u307e\u3057\u305f\u3002 \u3053\u308c\u3089\u306e\u5224\u65ad\u306f\u591a\u304f\u306e\u95a2\u4fc2\u8005\u306b\u3068\u3063\u3066\u610f\u5916\u306a\u3082\u306e\u3067\u3057\u305f\u3002tolebrutinib\u306f\u512a\u5148\u5be9\u67fb\u304a\u3088\u3073\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u30bb\u30e9\u30d4\u30fc\u6307\u5b9a\u306e\u4e21\u65b9\u3092\u53d7\u3051\u3066\u304a\u308a\u3001\u4e00\u65b9\u3067relacorilant\u306e\u4e3b\u8981\u8a66\u9a13\u3067\u3042\u308bGRACE\u8a66\u9a13\u306f\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3092\u9054\u6210\u3057\u3001\u3055\u3089\u306bGRADIENT\u8a66\u9a13\u306e\u78ba\u8a8d\u7684\u30c7\u30fc\u30bf\u306b\u3088\u308b\u88cf\u4ed8\u3051\u3082\u3042\u308a\u307e\u3057\u305f\u3002 Complete Response Letter\uff08CRL\uff09\u3068\u306f\u4f55\u304b\uff1f CRL\u306f\u3001FDA\u306e\u300capprovable letter\u300d\u304a\u3088\u3073\u300cnot approvable letter\u300d\u306b\u4ee3\u308f\u308b\u3082\u306e\u3068\u3057\u30662008\u5e74\u306b\u5c0e\u5165\u3055\u308c\u3001\u7533\u8acb\u5185\u5bb9\u306e\u307e\u307e\u3067\u306f\u627f\u8a8d\u3067\u304d\u306a\u3044\u3053\u3068\u3092\u4e2d\u7acb\u7684\u306b\u4f1d\u3048\u308b\u4ed5\u7d44\u307f\u3068\u3057\u3066\u8a2d\u8a08\u3055\u308c\u307e\u3057\u305f\u3002\u3082\u3063\u3068\u3082\u3001\u516c\u5f0f\u306b\u306f\u4e2d\u7acb\u3067\u3042\u3063\u3066\u3082\u3001CRL\u306b\u306f\u5927\u304d\u306a\u610f\u5473\u304c\u3042\u308a\u307e\u3059\u3002FDA\u304c\u8a8d\u8b58\u3057\u305f\u5177\u4f53\u7684\u306a\u4e0d\u5099\u3092\u8a73\u8ff0\u3057\u3001\u901a\u5e38\u306f\u305d\u308c\u3089\u306b\u5bfe\u5fdc\u3059\u308b\u305f\u3081\u306e\u624b\u9806\u3092\u63d0\u793a\u3059\u308b\u304b\u3089\u3067\u3059\u3002\u4e00\u822c\u7684\u306a\u7406\u7531\u3068\u3057\u3066\u306f\u3001\u8ffd\u52a0\u30c7\u30fc\u30bf\u3092\u8981\u3059\u308b\u5b89\u5168\u6027\u307e\u305f\u306f\u6709\u52b9\u6027\u4e0a\u306e\u61f8\u5ff5\u3001\u88fd\u9020\u307e\u305f\u306f\u54c1\u8cea\u7ba1\u7406\u4e0a\u306e\u4e0d\u5099\u3001\u4e0d\u5341\u5206\u306a\u30ea\u30b9\u30af\u7ba1\u7406\u8a08\u753b\u3001\u306a\u3089\u3073\u306b\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u8a55\u4fa1\u306b\u5fc5\u8981\u306a\u6839\u62e0\u306e\u4e0d\u8db3\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002 CRL\u306f\u5f8c\u9000\u3067\u306f\u3042\u308b\u304c\u3001\u975e\u627f\u8a8d\u3067\u306f\u306a\u3044 CRL\u306f\u78ba\u304b\u306b\u5f8c\u9000\u3067\u306f\u3042\u308a\u307e\u3059\u304c\u3001\u975e\u627f\u8a8d\u3092\u610f\u5473\u3059\u308b\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u304a\u3088\u305d41%\u306e\u7533\u8acb\u304cCRL\u3092\u53d7\u3051\u53d6\u308a\u3001\u305d\u306e\u3046\u3061\u534a\u6570\u8d85\u306f\u6700\u7d42\u7684\u306b\u627f\u8a8d\u306b\u81f3\u308a\u307e\u3059\u3002\u3053\u3046\u3057\u305f\u5224\u65ad\u306e\u80cc\u666f\u306b\u4f55\u304c\u3042\u3063\u305f\u306e\u304b\u3001\u305d\u3057\u3066\u6b21\u306b\u4f55\u304c\u8d77\u3053\u308b\u306e\u304b\u3092\u7406\u89e3\u3059\u308b\u3053\u3068\u306f\u3001\u898f\u5236\u5f53\u5c40\u306e\u671f\u5f85\u306b\u5bfe\u5fdc\u3057\u3088\u3046\u3068\u3059\u308b\u958b\u767a\u4f01\u696d\u306b\u3068\u3063\u3066\u91cd\u8981\u306a\u793a\u5506\u3092\u4e0e\u3048\u307e\u3059\u3002 Sanofi\u304a\u3088\u3073Corcept Therapeutics\u306b\u3068\u3063\u3066\u3001\u4eca\u5f8c\u306e\u9053\u7b4b\u306b\u306f\u9ad8\u5ea6\u306a\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3001\u5148\u4f8b\u5206\u6790\u3001\u305d\u3057\u3066\u6226\u7565\u7684\u306a\u30a8\u30d3\u30c7\u30f3\u30b9\u5275\u51fa\u304c\u6c42\u3081\u3089\u308c\u307e\u3059\u3002Clarivate\u306e\u7d71\u5408\u578bAI\u5bfe\u5fdc\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u898f\u5236\u5f53\u5c40\u306e\u610f\u601d\u6c7a\u5b9a\u652f\u63f4\u3001\u518d\u7533\u8acb\u6226\u7565\u306e\u5f37\u5316\u3001\u305d\u3057\u3066\u6cbb\u7642\u85ac\u3092\u60a3\u8005\u3078\u5c4a\u3051\u308b\u524d\u9032\u3092\u5f8c\u62bc\u3057\u3059\u308b\u3088\u3046\u8a2d\u8a08\u3055\u308c\u3066\u3044\u307e\u3059\u3002 &nbsp; \u898f\u5236\u4e0a\u306e\u8ab2\u984c\u304c\u7570\u306a\u308c\u3070\u3001\u5fc5\u8981\u306a\u6226\u7565\u3082\u7570\u306a\u308b \u500b\u5225\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u691c\u8a0e\u3059\u308b\u524d\u306b\u91cd\u8981\u306a\u306e\u306f\u3001Sanofi\u3068Corcept\u304c\u76f4\u9762\u3057\u3066\u3044\u308bCRL\u4e0a\u306e\u8ab2\u984c\u304c\u672c\u8cea\u7684\u306b\u7570\u306a\u308a\u3001\u305d\u308c\u305e\u308c\u306b\u5408\u308f\u305b\u305f\u5bfe\u5fdc\u304c\u5fc5\u8981\u3060\u3068\u8a8d\u8b58\u3059\u308b\u3053\u3068\u3067\u3059\u3002 Sanofi\u306etolebrutinib\u304c\u76f4\u9762\u3057\u3066\u3044\u308b\u306e\u306f\u3001\u5b89\u5168\u6027\u306b\u7126\u70b9\u3092\u5f53\u3066\u305fCRL\u3067\u3042\u308a\u3001FDA\u306f\u91cd\u7be4\u306a\u85ac\u5264\u6027\u809d\u969c\u5bb3\uff08DILI\uff09\u306e\u30ea\u30b9\u30af\u3092\u300c\u91cd\u5927\u304b\u3064\u7570\u4f8b\u306b\u9ad8\u3044\u300d\u3068\u4f4d\u7f6e\u4ed8\u3051\u307e\u3057\u305f\u3002FDA\u306f\u3055\u3089\u306b\u3001\u300c\u5229\u76ca\u304c\u660e\u78ba\u306b\u793a\u3055\u308c\u3001\u304b\u3064\u305d\u306e\u5229\u76ca\u304c\u91cd\u7be4\u306aDILI\u306e\u91cd\u5927\u306a\u30ea\u30b9\u30af\u3092\u4e0a\u56de\u308b\u3068\u671f\u5f85\u3067\u304d\u308b\u60a3\u8005\u96c6\u56e3\u3092\u7279\u5b9a\u3067\u304d\u306a\u304b\u3063\u305f\u300d\u3068\u7d50\u8ad6\u3065\u3051\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306fSanofi\u306b\u5bfe\u3057\u3001\u30ea\u30b9\u30af\u6700\u5c0f\u5316\u6226\u7565\u306e\u5f37\u5316\u3001\u3088\u308a\u4f4e\u30ea\u30b9\u30af\u306a\u60a3\u8005\u30b5\u30d6\u30b0\u30eb\u30fc\u30d7\u306e\u7279\u5b9a\u3001\u3042\u308b\u3044\u306f\u8ffd\u52a0\u306e\u5b89\u5168\u6027\u30a8\u30d3\u30c7\u30f3\u30b9\u306e\u5275\u51fa\u3092\u6c42\u3081\u308b\u3082\u306e\u3067\u3059\u3002 \u4e00\u65b9\u3001Corcept\u306erelacorilant\u304c\u53d7\u3051\u53d6\u3063\u305f\u306e\u306f\u3001\u30a8\u30d3\u30c7\u30f3\u30b9\u306e\u5341\u5206\u6027\u306b\u95a2\u3059\u308bCRL\u3067\u3057\u305f\u3002FDA\u306fGRACE\u8a66\u9a13\u304c\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3092\u9054\u6210\u3057\u305f\u3053\u3068\u306f\u8a8d\u3081\u3064\u3064\u3082\u3001\u300cCorcept\u304c\u6709\u52b9\u6027\u306b\u95a2\u3059\u308b\u8ffd\u52a0\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u63d0\u793a\u3057\u306a\u3044\u9650\u308a\u3001relacorilant\u306b\u3064\u3044\u3066\u826f\u597d\u306a\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u8a55\u4fa1\u306b\u306f\u5230\u9054\u3067\u304d\u306a\u3044\u300d\u3068\u8ff0\u3079\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u3001\u7570\u8cea\u6027\u306e\u9ad8\u3044\u30af\u30c3\u30b7\u30f3\u30b0\u75c7\u5019\u7fa4\u60a3\u8005\u96c6\u56e3\u5168\u4f53\u306b\u304a\u3044\u3066\u3001\u81e8\u5e8a\u7684\u610f\u7fa9\u3068\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u3092\u3088\u308a\u5305\u62ec\u7684\u306b\u793a\u3059\u5fc5\u8981\u304c\u3042\u308b\u3053\u3068\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002 &nbsp; Clarivate\u306e\u7d71\u5408\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u57fa\u76e4\u306f\u3044\u304b\u306bCRL\u5bfe\u5fdc\u3092\u652f\u63f4\u3059\u308b\u304b Clarivate\u306e\u7d71\u5408\u30c7\u30fc\u30bf\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068AI\u642d\u8f09\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306b\u5bfe\u3057\u3066\u3001\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3001\u5206\u6790\u529b\u3001\u305d\u3057\u3066\u6226\u7565\u7684\u6d1e\u5bdf\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002AI\u3092\u6d3b\u7528\u3057\u305f\u5f53\u793e\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\u306f\u3001\u533b\u85ac\u54c1\u958b\u767a\u304a\u3088\u3073\u5546\u696d\u5316\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u306b\u308f\u305f\u308a\u3001\u300c\u554f\u3044\u300d\u304b\u3089\u300c\u6d1e\u5bdf\u300d\u307e\u3067\u306e\u6642\u9593\u3092\u5287\u7684\u306b\u77ed\u7e2e\u3067\u304d\u307e\u3059\u3002\u5f93\u6765\u306f\u6570\u9031\u9593\u306e\u624b\u4f5c\u696d\u5206\u6790\u3092\u8981\u3057\u305f\u30d7\u30ed\u30bb\u30b9\u3092\u3001\u6570\u6642\u9593\u3067\u5f97\u3089\u308c\u308b\u6d1e\u5bdf\u3078\u3068\u5909\u3048\u308b\u3053\u3068\u304c\u53ef\u80fd\u3067\u3059\u3002 \u3053\u306e\u7d71\u5408\u30a2\u30d7\u30ed\u30fc\u30c1\u306f\u3001Drugs to&#8230;<\/p>\n","protected":false},"author":141,"featured_media":574158,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_links_to":"","_links_to_type":0,"footnotes":""},"categories":[1309],"tags":[1086,2597,2703,2767,1225,2639,2603,2606,1120,2786,2734],"class_list":["post-574218","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biopharma","tag-biopharma","tag-biotech","tag-clinical-trials","tag-commercialization","tag-fda","tag-market-access-2","tag-pharma","tag-real-world-data","tag-regulatory-ja","tag-safety","tag-u-s"],"acf":[],"lang":"ja","translations":{"ja":574218,"en":574157,"ko":579582},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/574218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/users\/141"}],"replies":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/comments?post=574218"}],"version-history":[{"count":7,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/574218\/revisions"}],"predecessor-version":[{"id":585337,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/574218\/revisions\/585337"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media\/574158"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=574218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/categories?post=574218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/tags?post=574218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}